United States · FDA National Drug Code directory
HYDRALAZINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71209-018_4cdbf75c-b17f-4c40-bd7c-7b07668e9659
- Product NDC
- 71209-018
- Form
- TABLET
- Composition / generic term
- hydralazine hydrochloride
- Labeler
- Cadila Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20151229
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDRALAZINE HYDROCHLORIDE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (71209-018-05) · 71209-018-05
- 1000 TABLET in 1 BOTTLE (71209-018-11) · 71209-018-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →